PMGC Holdings Inc (ELAB) Stock Analysis
Verdict: AVOID
A dying micro-cap pivot to GLP-1 muscle-preservation and AI drug discovery lacks the cash runway to survive its -746% operating margin.
Investment score: 28/100
Analysis as of
Is PMGC Holdings Inc stock worth reviewing? The TradeMates thesis
PMGC Holdings is a distressed micro-cap pharmaceutical firm with unsustainable margins and extreme dilution risk.
7-factor investment score
- Valuation: 30/100 (weight 20%)
- Financial Health: 10/100 (weight 15%)
- Technical Momentum: 35/100 (weight 15%)
- Earnings Quality: 5/100 (weight 15%)
- Insider Sentiment: 40/100 (weight 10%)
- Analyst Consensus: 20/100 (weight 10%)
- Risk-Adjusted Return: 45/100 (weight 15%)
PMGC Holdings Inc opportunities and risks
What speaks for ELAB
- GLP-1 Adjacency via EL-22
What speaks against ELAB
- Imminent Liquidity Crunch
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| ELAB | n/a | 1.9x | 0.4x | 12.7% | -873.1% | -339.3% |
| PAVS | n/a | 0.5x | n/a | 9.7% | -51.5% | -33.0% |
| MTEX | n/a | 0.1x | 8.1x | 75.3% | -12.0% | -14.4% |
| BRGX | n/a | 4.2x | n/a | 81.9% | -73.8% | 0.3% |
| INBP | n/a | 0.1x | 55.5x | 4.6% | -3.4% | 50.5% |
| DNDT | n/a | 0.0x | n/a | 0.0% | 0.0% | 0.0% |
| Peer median | n/a | 0.1x | n/a | 9.7% | -12.0% | 0.0% |
Frequently asked questions about PMGC Holdings Inc (ELAB)
Is ELAB stock a good investment?
The TradeMates model rates PMGC Holdings Inc as AVOID with an investment score of 28/100. PMGC Holdings is a distressed micro-cap pharmaceutical firm with unsustainable margins and extreme dilution risk. This is algorithmic model output, not personal investment advice.
Is ELAB stock a buy?
The TradeMates model verdict for ELAB is AVOID with an investment score of 28/100. Treat this as a model signal to review, not a personal buy recommendation.